175 related articles for article (PubMed ID: 10728705)
21. Mucin1 mediates autocrine transforming growth factor beta signaling through activating the c-Jun N-terminal kinase/activator protein 1 pathway in human hepatocellular carcinoma cells.
Li Q; Liu G; Shao D; Wang J; Yuan H; Chen T; Zhai R; Ni W; Tai G
Int J Biochem Cell Biol; 2015 Feb; 59():116-25. PubMed ID: 25526895
[TBL] [Abstract][Full Text] [Related]
22. Evidence for TGF-beta1 and bleomycin intracellular signaling through autocrine regulation of Smad 3 binding to the proximal promoter of the Smad 7 gene.
Cutroneo KR
J Cell Biochem; 2006 Apr; 97(5):933-9. PubMed ID: 16187293
[TBL] [Abstract][Full Text] [Related]
23. Selective inhibition of TGF-beta responsive genes by Smad-interacting peptide aptamers from FoxH1, Lef1 and CBP.
Cui Q; Lim SK; Zhao B; Hoffmann FM
Oncogene; 2005 Jun; 24(24):3864-74. PubMed ID: 15750622
[TBL] [Abstract][Full Text] [Related]
24. A novel mechanism by which hepatocyte growth factor blocks tubular epithelial to mesenchymal transition.
Yang J; Dai C; Liu Y
J Am Soc Nephrol; 2005 Jan; 16(1):68-78. PubMed ID: 15537870
[TBL] [Abstract][Full Text] [Related]
25. RUNX3 suppresses gastric epithelial cell growth by inducing p21(WAF1/Cip1) expression in cooperation with transforming growth factor {beta}-activated SMAD.
Chi XZ; Yang JO; Lee KY; Ito K; Sakakura C; Li QL; Kim HR; Cha EJ; Lee YH; Kaneda A; Ushijima T; Kim WJ; Ito Y; Bae SC
Mol Cell Biol; 2005 Sep; 25(18):8097-107. PubMed ID: 16135801
[TBL] [Abstract][Full Text] [Related]
26. Smad7 antagonizes transforming growth factor beta signaling in the nucleus by interfering with functional Smad-DNA complex formation.
Zhang S; Fei T; Zhang L; Zhang R; Chen F; Ning Y; Han Y; Feng XH; Meng A; Chen YG
Mol Cell Biol; 2007 Jun; 27(12):4488-99. PubMed ID: 17438144
[TBL] [Abstract][Full Text] [Related]
27. Molecular pathogenesis of hepatocellular carcinoma: altering transforming growth factor-β signaling in hepatocarcinogenesis.
Yamazaki K; Masugi Y; Sakamoto M
Dig Dis; 2011; 29(3):284-8. PubMed ID: 21829019
[TBL] [Abstract][Full Text] [Related]
28. Altered expression of TGF-beta receptors in hepatocellular carcinoma--effects of a constitutively active TGF-beta type I receptor mutant.
Musch A; Rabe C; Paik MD; Berna MJ; Schmitz V; Hoffmann P; Nischalke HD; Sauerbruch T; Caselmann WH
Digestion; 2005; 71(2):78-91. PubMed ID: 15775675
[TBL] [Abstract][Full Text] [Related]
29. Compound Astragalus and Salvia miltiorrhiza extracts suppress hepatocarcinogenesis by modulating transforming growth factor-β/Smad signaling.
Hu X; Rui W; Wu C; He S; Jiang J; Zhang X; Yang Y
J Gastroenterol Hepatol; 2014 Jun; 29(6):1284-91. PubMed ID: 24329763
[TBL] [Abstract][Full Text] [Related]
30. Differential regulation of TGF-beta signal in hepatic stellate cells between acute and chronic rat liver injury.
Tahashi Y; Matsuzaki K; Date M; Yoshida K; Furukawa F; Sugano Y; Matsushita M; Himeno Y; Inagaki Y; Inoue K
Hepatology; 2002 Jan; 35(1):49-61. PubMed ID: 11786959
[TBL] [Abstract][Full Text] [Related]
31. Blocking transforming growth factor-beta up-regulates E-cadherin and reduces migration and invasion of hepatocellular carcinoma cells.
Fransvea E; Angelotti U; Antonaci S; Giannelli G
Hepatology; 2008 May; 47(5):1557-66. PubMed ID: 18318443
[TBL] [Abstract][Full Text] [Related]
32. Galangin suppresses HepG2 cell proliferation by activating the TGF-β receptor/Smad pathway.
Wang Y; Wu J; Lin B; Li X; Zhang H; Ding H; Chen X; Lan L; Luo H
Toxicology; 2014 Dec; 326():9-17. PubMed ID: 25268046
[TBL] [Abstract][Full Text] [Related]
33. Interferon-α2b and transforming growth factor-β1 treatments on HCC cell lines: Are Wnt/β-catenin pathway and Smads signaling connected in hepatocellular carcinoma?
Ceballos MP; Parody JP; Alvarez Mde L; Ingaramo PI; Carnovale CE; Carrillo MC
Biochem Pharmacol; 2011 Dec; 82(11):1682-91. PubMed ID: 21843516
[TBL] [Abstract][Full Text] [Related]
34. Oxygen regulation of TGF-beta 1 mRNA in human hepatoma (Hep G2) cells.
Patel B; Khaliq A; Jarvis-Evans J; McLeod D; Mackness M; Boulton M
Biochem Mol Biol Int; 1994 Oct; 34(3):639-44. PubMed ID: 7833842
[TBL] [Abstract][Full Text] [Related]
35. The growth inhibitory effects of vitamins K and their actions on gene expression.
Wang Z; Wang M; Finn F; Carr BI
Hepatology; 1995 Sep; 22(3):876-82. PubMed ID: 7657295
[TBL] [Abstract][Full Text] [Related]
36. Down-regulation of connective tissue growth factor by inhibition of transforming growth factor beta blocks the tumor-stroma cross-talk and tumor progression in hepatocellular carcinoma.
Mazzocca A; Fransvea E; Dituri F; Lupo L; Antonaci S; Giannelli G
Hepatology; 2010 Feb; 51(2):523-34. PubMed ID: 19821534
[TBL] [Abstract][Full Text] [Related]
37. Neuropilin-2 induced by transforming growth factor-β augments migration of hepatocellular carcinoma cells.
Wittmann P; Grubinger M; Gröger C; Huber H; Sieghart W; Peck-Radosavljevic M; Mikulits W
BMC Cancer; 2015 Nov; 15():909. PubMed ID: 26573807
[TBL] [Abstract][Full Text] [Related]
38. EVI1, a target gene for amplification at 3q26, antagonizes transforming growth factor-β-mediated growth inhibition in hepatocellular carcinoma.
Yasui K; Konishi C; Gen Y; Endo M; Dohi O; Tomie A; Kitaichi T; Yamada N; Iwai N; Nishikawa T; Yamaguchi K; Moriguchi M; Sumida Y; Mitsuyoshi H; Tanaka S; Arii S; Itoh Y
Cancer Sci; 2015 Jul; 106(7):929-37. PubMed ID: 25959919
[TBL] [Abstract][Full Text] [Related]
39. TGF-β signaling is often attenuated during hepatotumorigenesis, but is retained for the malignancy of hepatocellular carcinoma cells.
Mu X; Lin S; Yang J; Chen C; Chen Y; Herzig MC; Washburn K; Halff GA; Walter CA; Sun B; Sun LZ
PLoS One; 2013; 8(5):e63436. PubMed ID: 23704908
[TBL] [Abstract][Full Text] [Related]
40. Direct effect of branched-chain amino acids on the growth and metabolism of cultured human hepatocellular carcinoma cells.
Sugiyama K; Yu L; Nagasue N
Nutr Cancer; 1998; 31(1):62-8. PubMed ID: 9682250
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
